[go: up one dir, main page]

UA98124C2 - Застосування антагоніста прогестерону для лікування ендометріозу - Google Patents

Застосування антагоніста прогестерону для лікування ендометріозу

Info

Publication number
UA98124C2
UA98124C2 UAA200905097A UAA200905097A UA98124C2 UA 98124 C2 UA98124 C2 UA 98124C2 UA A200905097 A UAA200905097 A UA A200905097A UA A200905097 A UAA200905097 A UA A200905097A UA 98124 C2 UA98124 C2 UA 98124C2
Authority
UA
Ukraine
Prior art keywords
endometriosis
treatment
instant invention
subject matter
estrogen
Prior art date
Application number
UAA200905097A
Other languages
English (en)
Russian (ru)
Inventor
Джозеф С. Подольски
Original Assignee
Репрос Терапьютикс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Репрос Терапьютикс Инк. filed Critical Репрос Терапьютикс Инк.
Priority claimed from PCT/US2007/082432 external-priority patent/WO2008067086A2/en
Publication of UA98124C2 publication Critical patent/UA98124C2/uk

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UAA200905097A 2006-10-24 2007-10-24 Застосування антагоніста прогестерону для лікування ендометріозу UA98124C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86263206P 2006-10-24 2006-10-24
PCT/US2007/082432 WO2008067086A2 (en) 2006-10-24 2007-10-24 Compositions and methods for suppressing endometrial proliferation

Publications (1)

Publication Number Publication Date
UA98124C2 true UA98124C2 (uk) 2012-04-25

Family

ID=41095733

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200905097A UA98124C2 (uk) 2006-10-24 2007-10-24 Застосування антагоніста прогестерону для лікування ендометріозу

Country Status (4)

Country Link
CN (2) CN104997789A (uk)
RS (1) RS56491B1 (uk)
TW (1) TWI455716B (uk)
UA (1) UA98124C2 (uk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105963687A (zh) * 2016-04-27 2016-09-28 张金凤 一种用于治疗慢性盆腔疼痛的复方制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
ATE194358T1 (de) * 1996-05-01 2000-07-15 Us Gov Health & Human Serv 21-substituierte progesteron derivate als antigestagene
MX2007000273A (es) * 2004-07-09 2007-05-21 Population Council Inc Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona.

Also Published As

Publication number Publication date
CN104997789A (zh) 2015-10-28
RS56491B1 (sr) 2018-01-31
TWI455716B (zh) 2014-10-11
CN101528764A (zh) 2009-09-09
TW200822931A (en) 2008-06-01

Similar Documents

Publication Publication Date Title
MY161059A (en) Progesterone antagonists such as cdb-4214 in the treatment of embodimetriosis, uterine fibroids, dysmenorrhea, breast cancer etc
MY150763A (en) Compositions and methods for suppressing endometrial proliferation
MY161549A (en) Progesterone antagonists such as cdb-4124 in the treatment of breast cancer
MX394667B (es) El uso de 1-(4-ciano-3-trifluorometil-fenil)-3-[7-(4- ciano-3-trifluorometll-fen|l)-6-tioxo-5-p-tolilo-5,7-diazaespiro[3.4]oct-8-ilideno]-tiourea.
SG170809A1 (en) Diarylthiohydantoin compounds
MX2009000714A (es) Moduladores de receptor de androgeno selectivos, analogos y derivados de los mismos.
HUS1900030I1 (hu) Androgén receptor modulátorok a prosztatarák és androgén receptorral összefüggõ betegségek kezelésére
MX2010005221A (es) Tratamiento de cancer de utero y cancer de ovario con un inhibidor de parp solo o en combinacion con agentes antitumorales.
MY156264A (en) Cannabinoids in combination with non-cannabinoid chemotherapeutic agents (e.g serm or alkylating agents)
EA020326B9 (ru) Агонисты смешанного действия на основе глюкозозависимого инсулинотропного пептида для лечения нарушений обмена веществ и ожирения
JP2014503537A5 (uk)
MX2017013565A (es) Ligandos degradadores selectivos del receptor androgénico (sard) y sus métodos uso.
PH12013500618A1 (en) Therapeutic use of a tlr agonist and combination therapy
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
TN2010000214A1 (en) Methods for treating obesity and obesity related diseases and disorders
GB2479337A (en) Combination of a 17 alpha-hydroxylase/c17, 20-lyase inhibitor with an additional therapeutic agent
DE60324431D1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs
WO2009134725A3 (en) Monomethylamine progesteron antagonists such as cdb-4453 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
TN2009000136A1 (en) Sequential combination therapy
UA98124C2 (uk) Застосування антагоніста прогестерону для лікування ендометріозу
TW200726461A (en) Use of non-steroidal progesterone receptor modulators
TW200603802A (en) Method of treating neuropathic pain
IL195746A0 (en) Brassinosteroids for use in treating prostatic hyperplasia and androgenic alopecia